Elevance Health, Inc.
396.90USD
-5.0400 (-1.25%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 50,474 | 50,181 | 49,747 | 50,711 | 49,776 | 48,891 | 45,442 | 45,106 |
| Cost of Revenue | 5,492 | 5,463 | 5,522 | 5,380 | 5,293 | 4,983 | 6,012 | 5,093 |
| Gross Profit | 44,982 | 44,718 | 44,225 | 45,331 | 44,483 | 43,908 | 39,430 | 40,013 |
| Operating Income | 1,763 | 2,086 | 309 | 1,295 | 2,425 | 3,170 | 673 | 1,408 |
| Net Income | 1,463 | 1,764 | 547 | 1,189 | 1,743 | 2,183 | 418 | 1,016 |
| EPS (Diluted) | $6.71 | $8.00 | $2.54 | $5.32 | $7.72 | $9.61 | $1.87 | $4.36 |
Source: SEC filings (EDGAR)